University of Kansas Cancer Center Post San Antonio Review

 

University of Kansas Cancer Center Post San Antonio Review
Avatar

Early Stage HR+ BC: Optimizing Systemic Therapy

By University of Kansas Cancer Center Post San Antonio Review FEATURING Angela DeMichele
By University of Kansas Cancer Center Post San Antonio Review FEATURING Angela DeMichele
0 views
February 23, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
2022
46:01
University of Kansas Cancer Center Post San Antonio Review

Post SABCS Review: Q&A and Case Discussion - Gene Expression Tes…

Feat. P. Sharma, J. Klemp, A. DeMichele, A. Prat, W. Woodward, S. Stecklein
24:34
University of Kansas Cancer Center Post San Antonio Review

Post SABCS Review: Updates in Locoregional Therapy for Breast Cancer

Feat. W. Woodward
26:04
University of Kansas Cancer Center Post San Antonio Review

Integration of Biomarkers to Inform Treatment Decisions in Breast Ca…

Feat. A. Prat
31:32
University of Kansas Cancer Center Post San Antonio Review

Early Stage HR+ BC: Optimizing Systemic Therapy

Feat. A. DeMichele
46:12
University of Kansas Cancer Center Post San Antonio Review

Post SABCS Review Q&A and Case Discussion: TNBC, HER2+ De Novo m…

Feat. P. Sharma, J. Klemp, J. Cortes, M. Robson, S. Hurvitz
30:10
University of Kansas Cancer Center Post San Antonio Review

Post SABCS Review of HER2+ mBC: Novel Treatment Approaches

Feat. S. Hurvitz
28:05
University of Kansas Cancer Center Post San Antonio Review

2022 Inherited Breast Cancer Risk Assessment and Reduction: What…

Feat. M. Robson
23:20
University of Kansas Cancer Center Post San Antonio Review

Post SABCS Review of (Neo)Adjuvant Therapy for TNBC: Changing Paradi…

Feat. J. Cortes